MCID: CRN074
MIFTS: 46

Coronary Artery Aneurysm malady

Categories: Rare diseases, Cardiovascular diseases, Fetal diseases

Aliases & Classifications for Coronary Artery Aneurysm

About this section

Aliases & Descriptions for Coronary Artery Aneurysm:

Name: Coronary Artery Aneurysm 48
Coronary Artery Aneurysms 50
 
Coronary Aneurysm 68

Classifications:



External Ids:

ICD1030 I25.4

Summaries for Coronary Artery Aneurysm

About this section
Wikipedia:71 Coronary artery aneurysm is an abnormal dilatation of part of the coronary artery. more...

MalaCards based summary: Coronary Artery Aneurysm, also known as coronary artery aneurysms, is related to rheumatoid arthritis and congenital coronary artery aneurysm. An important gene associated with Coronary Artery Aneurysm is VCAM1 (Vascular Cell Adhesion Molecule 1), and among its related pathways are Syndecan-1-mediated signaling events and LDL Oxidation in Atherogenesis. Affiliated tissues include heart, t cells and lymph node, and related mouse phenotypes are homeostasis/metabolism and immune system.

Related Diseases for Coronary Artery Aneurysm

About this section

Diseases in the Coronary Artery Aneurysm family:

Congenital Coronary Artery Aneurysm

Diseases related to Coronary Artery Aneurysm via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 86)
idRelated DiseaseScoreTop Affiliating Genes
1rheumatoid arthritis29.2CCL2, MMP1, MMP13, MMP3, VCAM1
2congenital coronary artery aneurysm12.2
3kawasaki disease11.6
4aneurysm11.0
5myocardial infarction10.4
6symmastia10.3MMP1, MMP3
7acute myocardial infarction10.2
8coronary artery dissection, spontaneous10.2
9kleptomania10.2MMP1, MMP3, MMP7
10linear porokeratosis10.2MMP1, MMP12, MMP7
11cystic lymphangioma10.2MMP1, MMP3, MMP7
12arteriovenous fistula10.1
13synovium cancer10.1MMP1, MMP13, MMP3, VCAM1
14thrombosis10.1
15exophthalmic ophthalmoplegia10.1ADIPOQ, LEP, VCAM1
16acrocephalopolydactyly10.1ADIPOQ, LEP, RETN
17malignant perineurioma10.1ADIPOQ, LEP, RETN
18cardiac tamponade10.1
19not otherwise specified 3-mga-uria type10.1ADIPOQ, LEP, RETN
20cataract 20, multiple types10.0ADIPOQ, LEP, RETN
21coronary arterial fistulas10.0
22bone angioendothelial sarcoma10.0CCL2, MMP1, MMP13, MMP3
23mucopolysaccharidosis iii10.0ADIPOQ, LEP, RETN
24mucinoses10.0ADIPOQ, LEP, RETN, VCAM1
25chronic tic disorder10.0ADIPOQ, LEP, VCAM1
26mediastinitis10.0
27thymus clear cell carcinoma10.0ADIPOQ, LEP, RETN
28autistic disorder10.0CCL2, MMP1, MMP13, MMP3
29bare lymphocyte syndrome, type i10.0ADIPOQ, CCL2, VCAM1
30mixed ductal-endocrine carcinoma9.9CCL2, MMP1, MMP12, MMP13, MMP3
31endocarditis9.9
32antidepressant type abuse9.9ADIPOQ, LEP, RETN
33autoimmune-related retinopathy and optic neuropathy9.9ADIPOQ, CCL2, MMP3, VCAM1
34adrenal adenoma9.9ADIPOQ, CCL2, LEP, RETN
35aortic aneurysm, familial thoracic 69.9CCL17, CCL2, MMP1, MMP7, VCAM1
36body dysmorphic disorder9.9ADIPOQ, CCL2, LEP, RETN
37neurofibromatosis9.9
38pericarditis9.9ADIPOQ, CCL2, RETN, VCAM1
39hemolytic anemia, cd59-mediated, with or without immune-mediated polyneuropathy9.8ADIPOQ, LEP, RETN
40systemic lupus erythematosus9.8
41coronary artery disease9.8
42marfan syndrome9.8
43takayasu arteritis9.8
44atherosclerosis9.8
45artery disease9.8
46infective endocarditis9.8
47patent ductus arteriosus9.8
48cerebritis9.8
49aortic aneurysm9.8
50aortitis9.8

Graphical network of the top 20 diseases related to Coronary Artery Aneurysm:



Diseases related to coronary artery aneurysm

Symptoms & Phenotypes for Coronary Artery Aneurysm

About this section

MGI Mouse Phenotypes related to Coronary Artery Aneurysm according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053767.2ABHD16A, ADIPOQ, BAG6, ITPR3, LEP, MMP1
2MP:00053876.8ABHD16A, ADIPOQ, CCL17, CCL2, LEP, MMP1

Drugs & Therapeutics for Coronary Artery Aneurysm

About this section

Drugs for Coronary Artery Aneurysm (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 145)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
EverolimusapprovedPhase 4, Phase 3, Phase 1, Phase 21940159351-69-66442177
Synonyms:
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy
07741_FLUKA
159351-69-6
40-O-(2-hydroxyethyl)-rapamycin
42-O-(2-Hydroxyethyl)rapamycin
Afinitor
CERTICAN(R)
CHEMBL1201755
Certican
D02714
DB01590
 
Everolimus
Everolimus (JAN/USAN/INN)
Everolimus [USAN]
LS-143292
MolPort-003-847-342
MolPort-003-925-588
NCGC00167512-01
NVP-RAD-001
RAD 001
RAD-001
RAD-001C
RAD001
RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus
S1120_Selleck
SDZ-RAD
UNII-9HW64Q8G6G
Zortress
everolimus
2
TiclopidineapprovedPhase 447155142-85-35472
Synonyms:
5-((2-Chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine
5-(2-Chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine
55142-85-3
AC-15204
AC1L1KFB
BIDD:PXR0169
BPBio1_000191
BRD-K00603606-003-03-4
BRN 1216802
BSPBio_000173
C07140
C14H14ClNS
CAS-53885-35-1
CHEBI:9588
CHEMBL833
CID5472
D08594
DB00208
EINECS 259-498-5
HMS2089I18
L001108
LS-152434
MLS001201825
MolPort-002-507-849
 
NCGC00016872-01
NCGC00016872-02
NCGC00024361-04
PCR 5332
Prestwick0_000047
Prestwick1_000047
Prestwick2_000047
Prestwick3_000047
SMR000641861
SPBio_002094
STK589340
STOCK5S-54105
Ticlid
Ticlopidin-Puren
Ticlopidin-Puren (TN)
Ticlopidina
Ticlopidina [INN-Spanish]
Ticlopidine (INN)
Ticlopidine HCL
Ticlopidine Hydrochloride
Ticlopidine [INN:BAN]
Ticlopidinum
Ticlopidinum [INN-Latin]
UNII-OM90ZUW7M1
UNM-0000345023
ZINC19594599
ticlopidine
3
Sirolimusapproved, investigationalPhase 4, Phase 3, Phase 1, Phase 2194053123-88-95284616, 6436030, 46835353
Synonyms:
(-)-Rapamycin
(-)-rapamycin
1fkb
1pbk
23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine
23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine
23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29
3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
53123-88-9
A422989, NSC226080
AC-722
AC1L1JH9
AC1L7MJ9
AC1L9ZMV
AY 22989
AY-22989
AY22989
Ambotz53123-88-9
Antibiotic AY 22989
BIDD:PXR0165
Bio1_000293
Bio1_000782
Bio1_001271
Bio2_000375
Bio2_000855
BiomolKI2_000084
C07909
C51H79NO13
CBiol_002007
CCRIS 9024
CHEBI:100923
CHEBI:9168
CHEMBL413
CID10213190
CID10795871
CID11949238
CID11959112
CID313006
CID478951
CID5040
CID5284616
CID5358081
CID5374464
CID5460439
CID5497196
CID5924240
CID6436030
CID6610270
CID6610346
CID6711160
CID6713081
CID9833581
CID9854379
CID9854380
CID9962926
CID9962928
D00753
DB00877
DE-109
DivK1c_006936
 
FT-0082351
HMS2089A21
HSDB 7284
KBio1_001880
KBio2_000410
KBio2_002978
KBio2_005546
KBio3_000779
KBio3_000780
KBioGR_000410
KBioSS_000410
LCP-Siro
LMPK06000003
LS-143290
MLS000028373
MS-R001
MolMap_000043
MolPort-003-959-433
NCGC00021305-05
NCI60_001851
NCIMech_000355
NSC 226080
NSC226080
Perceiva
QTL1_000069
R0395_SIAL
R0395_SIGMA
RAP
RAPA
RPM
Rapammune
Rapamune
Rapamune (TN)
Rapamycin
Rapamycin (TN)
Rapamycin C-7, analog 4
Rapamycin Immunosuppressant Drug
Rapamycin from Streptomyces hygroscopicus
S1039_Selleck
SIIA 9268A
SILA 9268A
SILA9268A
SMP1_000255
SMR000058564
Sirolimus
Sirolimus (RAPAMUNE)
Sirolimus (USAN/INN)
Sirolimus [USAN:BAN:INN]
Sirolimus, Rapamune,Rapamycin
SpecPlus_000840
UNII-W36ZG6FT64
UNM-0000358684
WY-090217
Wy 090217
heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy
nchembio.100-comp4
nchembio.2007.42-comp2
nchembio.79-comp1
nchembio762-comp1
nchembio883-comp3
rapamycin
sirolimus
4
RamiprilapprovedPhase 415287333-19-55362129
Synonyms:
(2 S ,3 aS ,6 aS )-1[( S )-N-[( S )-1-Carboxy-3-phenylpropyl] alanyl] octahydrocyclopenta [ b ]pyrrole-2-carboxylic acid, 1-ethyl ester
(2S,3aS,6aS)-1-((S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl) octahydrocyclopenta[b]pyrrole-2-carboxylic acid
(2S,3aS,6aS)-1-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid, 1-ethyl ester
(2S,3aS,6aS)-1-((S)-N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrol-2-carbonsaeure
(2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid
(2S,3aS,6aS)-1-[(2S)-2-{[(1S)-1-ethoxycarbonyl-3-phenylpropyl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid
(2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (non-preferred name)
(2S-(1(R*(R*)),2alpha,3abeta,6abeta))-1-(2-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid.
(2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid
(2s,3as,6as)-1((s)-n-((s)-1-carboxy-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrole-2-carboxylic
(2s,3as,6as)-1-((s)-2-((s)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)-octahydrocyclopenta[b]p
(2s,3as,6as)-1-[(s)-2-((s)-1-ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-octahydro-cyclopenta[b]
126613-39-6
87333-19-5
AC-1347
AC1NSFPR
Acovil
Almirall Brand of Ramipril
Altace
Altace (TN)
Altace (tn)
Astra Brand of Ramipril
AstraZeneca Brand of Ramipril
Aventis Brand of Ramipril
Aventis Pharma Brand of Ramipril
BIDD:GT0803
BSPBio_003347
Bio-0651
C23H32N2O5
CHEBI:289203
CHEBI:8774
CHEMBL1168
CID5362129
CPD000466386
Carasel
Cardace
D00421
D017257
DB00178
Delix
HMS2051E04
HMS2090L11
HMS2093M10
HOE 498
HOE498
Hoe-498
Hoechst Brand of Ramipril
 
Hypren
Hytren
KBio2_002504
KBio2_005072
KBio2_007640
KBio3_002849
KBioGR_001858
KBioSS_002512
LS-58199
Lostapres
MLS000759523
MLS001216547
MLS001423965
MolPort-001-736-571
Monarch Brand of Ramipril
N-(1S-carboethoxy-3-phenylpropyl)-S-alanyl-cis,endo-2-azabicyclo[3.3.0]octane-3S-carboxylic Acid
NCGC00178127-01
Naprix
Pramace
Pramace (discontinued)
Promed Brand of Ramipril
Quark
R0404_SIGMA
Ramace
Ramipril
Ramipril (USP/INN)
Ramipril [USAN:INN:BAN]
Ramiprilum
Ramiprilum [Latin]
Ramipro, Tritace, Altace, Prilace, Ramipril
S1793_Selleck
SAM001246757
SAM002699899
SMR000466386
SPECTRUM1505214
STK801937
Spectrum3_001794
Spectrum4_001269
Spectrum5_001721
Spectrum_001958
Triatec
Tritace
UNII-L35JN3I7SJ
Unipril
Vesdil
Zabien
[2S,3aS,6aS]-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid
[2s,3as,6as]-1-[(2s)-2-[[(1s)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopen
ramipril
5
Valsartanapproved, investigationalPhase 4295137862-53-460846
Synonyms:
(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine
(S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine
(s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid
137862-53-4
AC-4543
AC1L1U1M
AC1Q5QIK
Ambap137862-53-4
Aventis brand of valsartan
BIDD:GT0345
BRD-K45158365-001-02-3
BSPBio_003501
Bio-0796
C081489
C24H29N5O3
CEPA brand of valsartan
CGP 48933
CGP-48933
CHEBI:9927
CHEMBL1069
CID60846
CPD000466318
D00400
DB00177
Diovan
Diovan (TN)
Diovan, Valsartan
Esteve brand of valsartan
HMS1922L21
HMS2051L12
HMS2093K22
HSDB 7519
KBio2_002287
KBio2_004855
KBio2_007423
KBio3_003006
KBioGR_001078
KBioSS_002289
 
Kalpress
L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI)
LS-161334
Lacer brand of valsartan
MLS000759423
MLS001424088
Miten
MolPort-002-507-854
MolPort-003-666-608
N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine
N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine
N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine
N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine
N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine
Nisis
Nisis||
Novartis brand of valsartan
Provas
S1894_Selleck
SAM001246581
SMR000466318
SPBio_001260
SPECTRUM1505209
Sanol brand of valsartan
Schwarz brand of valsartan
Spectrum2_001120
Spectrum3_001831
Spectrum4_000749
Spectrum5_001582
Spectrum_001796
TL8000869
Tareg
UNII-80M03YXJ7I
Vals
Valsarran
Valsartan (JAN/USAN/INN)
Valsartan [USAN:INN]
valsartan
walsartan
|Tareg
6
Miconazoleapproved, investigational, vet_approvedPhase 4, Phase 3, Phase 1, Phase 2370622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
7
Sufentanilapproved, investigationalPhase 418556030-54-741693
Synonyms:
56030-54-7
60561-17-3 (citrate)
AC1L26AJ
AC1Q5I7B
C08022
C22H30N2O2S
CHEBI:127638
CHEBI:9316
CHEMBL658
CID41693
Chronogesic
D05938
DB00708
HSDB 6760
L000580
LS-175693
MolPort-004-286-008
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide
 
N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide
N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide
N-{4-[(methyloxy)methyl]-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide
Oprea1_120838
Oprea1_246787
PDSP1_001741
PDSP2_001724
R 30730
R-30730
SUFENTANIL
Sufentanil
Sufentanil (USAN/INN)
Sufentanil Citrate
Sufentanil [USAN:BAN:INN]
Sufentanilo
Sufentanilum
Sufentanilum [INN-Latin]
Sufentanyl
Sulfentanil
Sulfentanyl
UNII-AFE2YW0IIZ
8
Aspirinapproved, vet_approvedPhase 4, Phase 3, Phase 2115250-78-22244
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(Acetyloxy)benzoate
2-(Acetyloxy)benzoic acid
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
2349-94-2
26914-13-6
50-78-2
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. Empirin
A.S.A. empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
ACETYLSALICYLIC ACID
AI3-02956
AIN
AKOS000118884
ASA
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalicylsäure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acide acetylsalicylique
Acido O-acetil-benzoico
Acido acetilsalicilico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
Aloxiprimum
Asacard
Asagran
Asatard
Ascoden-30
Aspalon
Aspec
Aspergum
Aspir-Mox
Aspirdrops
Aspirin
Aspirin (JP15/USP)
Aspirin [BAN:JAN]
Aspirina 03
Aspirine
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
BIDD:GT0118
BRN 0779271
Bay-e-4465
Bayer
Bayer Aspirin 8 Hour
Bayer Buffered
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Plus
Benaspir
Bi-prin
Bialpirina
Bialpirinia
Bufferin
C01405
CCRIS 3243
CHEBI:15365
CHEMBL25
CID2244
Caprin
Cardioaspirin
Cardioaspirina
Cemirit
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dispril
DivK1c_000555
Dolean pH 8
Duramax
ECM
EINECS 200-064-1
EU-0100038
Easprin
Easprin (TN)
Ecolen
Ecotrin
Empirin
Empirin with Codeine
Endosprin
Endydol
Entericin
Enterophen
 
Enterosarein
Enterosarine
Entrophen
Extren
Globentyl
Globoid
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
Helicon
I14-7505
IDI1_000555
Idragin
Istopirin
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kapsazal
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LS-143
Levius
Lopac-A-5376
Lopac0_000038
MLS001055329
MLS001066332
MLS001336045
MLS001336046
Magnecyl
Measurin
Medisyl
Micristin
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
NCI60_002222
NINDS_000555
NSC 27223
NSC27223
NSC406186
Neuronika
Novid
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-Acetoxybenzoate
O-Acetoxybenzoic acid
O-Acetylsalicylic acid
O-Carboxyphenyl acetate
O-accetylsalicylic acid
O-acetylsalicylic acid
PL-2200
Persistin
Pharmacin
Pirseal
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
S-211
SMR000059138
SP 189
SPBio_001838
SPECTRUM1500130
ST075414
Salacetin
Salcetogen
Saletin
Salicylic acid acetate
Salicylic acid, acetate
Salospir
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spectrum_001245
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
Supac
Tasprin
Temperal
Toldex
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII-R16CO5Y76E
UNII=R16CO5Y76E
UNM-0000306102
Vanquish
WLN: QVR BOV1
XAXA
Xaxa
Yasta
ZORprin
acide 2-(acétyloxy)benzoïque
acide acétylsalicylique
aspirin
cMAP_000006
component of Midol
component of Synirin
nchem.859-comp6
o-Acetoxybenzoic acid
o-Carboxyphenyl acetate
o-acetoxybenzoic acid
o-carboxyphenyl acetate
salicylic acid acetate
ácido acetilsalicílico
9
SpironolactoneapprovedPhase 42321952-01-7, 52-01-75833
Synonyms:
4-18-00-01601 (Beilstein Handbook Reference)
4-Pregnen-21-oic acid-17alpha-ol-3-one-7alpha-thiol gamma-lactone 7-acetate
496916-40-6
52-01-7
7-alpha-Acetylthio-3-oxo-17-alpha-pregn-4-ene-21,17-beta-carbolactone
7alpha-(acetylsulfanyl)-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone
AB00513806
AC-4214
AC1L1L8Q
Abbolactone
Acelat
Aldace
Aldactazide
Aldactide
Aldactone
Aldactone (TN)
Aldactone A
Alderon
Aldopur
Almatol
Alphapharm Brand of Spironolactone
Alpharma Brand of Spironolactone
Alter Brand of Spironolactone
Altex
Aquareduct
Ashbourne Brand of Spironolactone
Azupharma Brand of Spironolactone
BIDD:PXR0071
BPBio1_000194
BRD-K90027355-001-03-4
BRN 0057767
BSPBio_000176
C07310
C24H32O4S
CHEBI:428201
CHEBI:45692
CHEBI:9241
CHEMBL1393
CID5833
CPD000471892
Cardel Brand of Spironolactone
D00443
D013148
DB00421
Deverol
Dexo Brand of Spironolactone
Diatensec
Dira
Duraspiron
EINECS 200-133-6
Espironolactona
Espironolactona Alter
Espironolactona Mundogen
Espironolactona [INN-Spanish]
Euteberol
Flumach
Frumikal
Generosan Brand of Spironolactone
HMS1568I18
HMS2090N21
HSDB 3184
Hormosan Brand of Spironolactone
I06-1970
Jenapharm Brand of Spironolactone
Jenaspiron
LS-118614
LT00772287
Lacalmin
Lacdene
Laractone
MLS001074672
MLS001333253
MLS001333254
MLS002153245
MLS002207058
Mayoly-Spindler Brand of Spironolactone
Melarcon
Merck dura Brand of Spironolactone
Mundogen Brand of Spironolactone
NCGC00164397-01
 
NCGC00164397-02
NSC 150399
NSC150399
Nefurofan
Novo Spiroton
Novo-Spiroton
NovoSpiroton
Novopharm Brand of Spironolactone
Osyrol
Pfizer Brand of Spironolactone
Pharmafrid Brand of Spironolactone
Practon
Prestwick0_000128
Prestwick1_000128
Prestwick2_000128
Prestwick3_000128
Roche Brand of Spironolactone
S0260
S3378_SIGMA
SAM002264648
SC 9420
SC-9420
SC9420
SMR000471892
SNL
SPBio_002115
Sagisal
Searle Brand of Spironolactone
Sincomen
Spiractin
Spiresis
Spiretic
Spiridon
Spiro L.U.T.
Spiro(17H-cyclopenta(a)phenauthrene-17,2'-(3'H)-furan)
Spiro-Tablinen
Spiro[17H-cyclopenta[a]phenauthrene-17,2'-(3'H)-furan]
Spirobeta
Spiroctan
Spiroctanie
Spiroderm
Spirogamma
Spirolactone
Spirolakton
Spirolang
Spirolone
Spirone
Spirono Isis
Spirono-Isis
Spironocompren
Spironolactone
Spironolactone (JP15/USP/INN)
Spironolactone A
Spironolactone [BAN:INN:JAN]
Spironolactone [INN:BAN:JAN]
Spironolactonum
Spironolactonum [INN-Latin]
Spironolattone
Spironolattone [DCIT]
Spironone
Spirospare
Sprioderm
Supra-puren
Suracton
UNII-27O7W4T232
Uractone
Urusonin
Veroshpiron
Verospiron
Verospirone
Verospirone Opianin
WLN: L E5 B666 FX OV MUTJ A1 E1 KSV1 F-& CT5VOXTJ
Worwag Brand of Spironolactone
Xenalon
ZINC03861599
betapharm Brand of Spironolactone
ct Arzneimittel Brand of Spironolactone
ct-Arzneimittel Brand of Spironolactone
spiro von ct
spironolactone
spironolattone
von ct, spiro
10
EplerenoneapprovedPhase 496107724-20-9150310, 443872
Synonyms:
107724-20-9
7alpha-methoxycarbonyl-3-oxo-9,11alpha-epoxy-17alpha-pregn-4-ene-21,17-carbolactone
AC-4213
AC1L9FDC
C12512
CGP-30083
CHEBI:31547
CHEBI:726453
CHEMBL1095097
CID443872
D01115
Eplerenone
 
Eplerenone (JAN/USAN/INN)
Epoxymexrenone
Inspra
Inspra (TN)
Inspra, Epoxymexrenone, CGP30083, SC-66110,Eplerenone
MolPort-003-986-216
NCGC00159559-01
NCGC00159559-02
S1707_Selleck
SC-66110
Selara
TL8000270
ZINC03985982
11
Clopidogrelapproved, nutraceuticalPhase 4778120202-66-6, 113665-84-260606
Synonyms:
( )-(S)-Clopidogrel
(+)-(S)-Clopidogrel
(+)-Clopidogrel
(S)-Clopidogrel
(S)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate
113665-84-2
AC-19024
AC1L1TKZ
AC1Q41I9
BIDD:GT0284
BRD-K27721098-065-02-9
BSPBio_003211
C16H16ClNO2S
CGE
CHEBI:37941
CHEMBL1771
CID60606
CLOPIDOGREL SULFATE
CPD000550475
Clopidogrel
Clopidogrel (INN)
Clopidogrel (TN)
Clopidogrel [BAN:INN]
Clopidogrel [Ban:Inn]
Clopidogrel [INN:BAN]
Clopidogrel bisulfate
Clopidogrel bisulphate
Clopidogrel sulfate
Clopidogrelum
D07729
DB00758
DivK1c_000787
HMS2090O21
HMS502H09
HSDB 7430
IDI1_000787
 
Isocover
KBio1_000787
KBio2_000545
KBio2_003113
KBio2_005681
KBio3_002431
KBioGR_000689
KBioSS_000545
LS-172232
MLS001165708
MLS001195633
MLS001304711
Methyl (+)-(S)-alpha-(o-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4H)-acetate
MolPort-002-885-817
MolPort-003-845-991
NCGC00163329-02
NINDS_000787
Plavix
Plavix (TN)
SAM002589956
SMR000550475
SPBio_000463
SR 25990
STK580572
STOCK5S-27782
Spectrum2_000512
Spectrum3_001606
Spectrum4_000175
Spectrum_000105
TL8000400
UNII-A74586SNO7
Zyllt
clopidogrel
clopidogrel, (+)(S)-isomer
methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate
methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate
nchem.651-comp8
12Angiotensin Receptor AntagonistsPhase 4, Phase 31191
13AngiotensinogenPhase 4, Phase 31177
14Angiotensin II Type 1 Receptor BlockersPhase 4, Phase 31091
15
Angiotensin IIPhase 4, Phase 3117868521-88-0, 11128-99-765143, 172198
Synonyms:
1-8-Angiotensin I
1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide
Ang II
Angiotensin 2
Angiotensin II (human)
 
Angiotensin II (mouse)
Angiotonin
Asp-arg-val-TYR-ile-his-pro-phe
Human angiotensin II
Hypertensin
Ile(5)-angiotensin II
16Cytochrome P-450 Enzyme InhibitorsPhase 43917
17Neurotransmitter AgentsPhase 4, Phase 318340
18Platelet Aggregation InhibitorsPhase 4, Phase 32516
19Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 122062
20Central Nervous System DepressantsPhase 4, Phase 313403
21Antifungal AgentsPhase 4, Phase 3, Phase 1, Phase 23696
22Anti-Bacterial AgentsPhase 4, Phase 3, Phase 2, Phase 111226
23Antibiotics, AntitubercularPhase 4, Phase 3, Phase 1, Phase 27180
24
protease inhibitorsPhase 45471
Synonyms:
 
protease inhibitors
25Rosuvastatin CalciumPhase 4476147098-20-2
26Angiotensin-Converting Enzyme InhibitorsPhase 4724
27Lipid Regulating AgentsPhase 4, Phase 3, Phase 22766
28Fibrinolytic AgentsPhase 4, Phase 22388
29Purinergic P2 Receptor AntagonistsPhase 4795
30Purinergic P2Y Receptor AntagonistsPhase 4793
31Immunosuppressive AgentsPhase 4, Phase 3, Phase 1, Phase 213086
32Anticholesteremic AgentsPhase 4, Phase 3, Phase 22025
33Antihypertensive AgentsPhase 4, Phase 34207
34Hypolipidemic AgentsPhase 4, Phase 3, Phase 22785
35Hydroxymethylglutaryl-CoA Reductase InhibitorsPhase 4, Phase 3, Phase 21998
36HIV Protease InhibitorsPhase 45470
37AntimetabolitesPhase 4, Phase 3, Phase 212054
38Calcium, DietaryPhase 4, Phase 2, Phase 35713
39Hypnotics and SedativesPhase 4, Phase 32616
40Anesthetics, IntravenousPhase 4, Phase 32538
41Natriuretic AgentsPhase 4, Phase 1, Phase 21697
42Anesthetics, GeneralPhase 4, Phase 32934
43diureticsPhase 4, Phase 1, Phase 21418
44NarcoticsPhase 43646
45AnalgesicsPhase 411733
46AntipyreticsPhase 41605
47Anti-Inflammatory Agents, Non-SteroidalPhase 44443
48Anti-Inflammatory AgentsPhase 410729
49Analgesics, Non-NarcoticPhase 46501
50AnestheticsPhase 4, Phase 3, Phase 19596

Interventional clinical trials:

(show top 50)    (show all 135)
idNameStatusNCT IDPhase
1Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTingUnknown statusNCT00698607Phase 4
2Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCADUnknown statusNCT02008786Phase 4
3A Morbidity-Mortality and Remodeling Study With ValsartanUnknown statusNCT00133328Phase 4
4Trial to Assess the Efficacy of Combination Formula of Aspirin Plus Clopidogrel in Patients With Coronary StentCompletedNCT02410083Phase 4
5Prevalence of Abdominal Aortic Aneurysm in Patients Undergoing Coronary AngiographyCompletedNCT01239225Phase 4
6Randomized Trial of Pulsatile vs Non Pulsatile Perfusion on Short Term Changes in Kidney Function Using an Intra-Aortic Ballooon Pump During Cardioplegic Arrest in Patients Undergoing Myocardial ReperfusionCompletedNCT00454428Phase 4
7XIENCE V: SPIRIT WOMEN Sub-studyCompletedNCT01182428Phase 4
8The Pharmacokinetics of Opioids and Sedative/Hypnotics During Selective Cerebral PerfusionCompletedNCT00494598Phase 4
9Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)CompletedNCT00149227Phase 4
10MAPS Trial: Matrix And Platinum ScienceCompletedNCT00396981Phase 4
11Eplerenone in the Management of Abdominal Aortic AneurysmsRecruitingNCT02345590Phase 4
12Clinical Evaluation of a Modular Extracorporeal Circulation CircuitUnknown statusNCT02000544Phase 3
13Transradial Versus Transulnar Artery Approach for Coronary InterventionsUnknown statusNCT01364532Phase 3
14Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive PatientsUnknown statusNCT00125463Phase 3
15Trial of Pulse Steroid Therapy in Kawasaki Disease--Pediatric Heart NetworkCompletedNCT00132080Phase 3
16Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stents to Treat De Novo Coronary LesionsCompletedNCT00301522Phase 2, Phase 3
17Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent RestenosisCompletedNCT00287573Phase 2, Phase 3
18SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent SystemCompletedNCT00180453Phase 3
19RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention (RADIAL-CABG) TrialCompletedNCT01446263Phase 3
20SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent SystemCompletedNCT00180310Phase 3
21Angio-Seal® vs. Exo-Seal® for Closure of Arterial Puncture SitesCompletedNCT01669382Phase 3
22ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical InvestigationCompletedNCT00300131Phase 3
23SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)CompletedNCT00180479Phase 3
24VALOR: The Talent Thoracic Stent Graft System Clinical StudyCompletedNCT00604799Phase 2, Phase 3
25Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)CompletedNCT00064753Phase 2, Phase 3
26Esmolol Infusion in Patients Undergoing CraniotomyCompletedNCT02455440Phase 3
27Simvastatin in Aneurysmal Subarachnoid Haemorrhage (STASH) a Multicentre Randomised Controlled Clinical TrialCompletedNCT00731627Phase 3
28Lowering the Risk of Operative Complications Using Atorvastatin Loading DoseCompletedNCT01543555Phase 3
29KIDCARE (Kawasaki Disease Comparative Effectiveness Trial)RecruitingNCT03065244Phase 3
30Induced Hypertension for Treatment of Delayed Cerebral Ischaemia After Aneurysmal Subarachnoid HaemorrhageTerminatedNCT01613235Phase 3
31Trial of Atorvastatin on the Persistent Coronary Aneurysm in Children With Kawasaki DiseaseUnknown statusNCT02114099Phase 2
32Prevention of Coronary Aneurysms in Kawasaki SyndromeCompletedNCT00000520Phase 2
33Pharmacokinetics of AP214 Acetate in Patients Undergoing Cardiac SurgeryCompletedNCT00903604Phase 2
34An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac SurgeryCompletedNCT01256372Phase 2
35Safety Study of Dantrolene in Subarachnoid HemorrhageCompletedNCT01024972Phase 1, Phase 2
36The Transfusion Triggers in Vascular Surgery TrialCompletedNCT02465125Phase 2
37Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki DiseaseRecruitingNCT01917721Phase 2
38Anakinra and Kawasaki DiseaseRecruitingNCT02390596Phase 2
39Evaluation of Branch Endografts in the Treatment of Aortic AneurysmsRecruitingNCT01524211Phase 2
40Safety and Feasibility of Hypertonic Saline Solution After Aneurysmal Subarachnoid Hemorrhage:RecruitingNCT02432157Phase 1, Phase 2
41ABSORB Clinical Investigation, Cohort BActive, not recruitingNCT00856856Phase 1, Phase 2
42Thrombolysis in Ischemic Spinal Cord StrokeActive, not recruitingNCT02242084Phase 2
43Safety, Tolerability and Pharmacodynamics of AP214 Acetate in Patients Undergoing Cardiac SurgeryTerminatedNCT00628264Phase 2
44Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki DiseaseWithdrawnNCT02980263Phase 2
45A Web-Based Cardiovascular Intervention for the WorkplaceUnknown statusNCT00763308Phase 1
46Preventing Myocardial Ischemia by Preconditioning in Elective Operation for Abdominal Aortic AneurysmUnknown statusNCT01523262Phase 1
47Clinical Study of Aneurysm ExclusionUnknown statusNCT00549380Phase 1
48Goal Directed Therapy for Patients Undergoing Major Vascular SurgeryCompletedNCT01681251Phase 1
49Remote Ischemic Preconditioning in Subarachnoid HemorrhageCompletedNCT01158508Phase 1
50Intraoperative Nasal Insulin Effect on Plasma and CSF Insulin Concentration and Blood GlucoseRecruitingNCT02729064Phase 1

Search NIH Clinical Center for Coronary Artery Aneurysm

Genetic Tests for Coronary Artery Aneurysm

About this section

Anatomical Context for Coronary Artery Aneurysm

About this section

MalaCards organs/tissues related to Coronary Artery Aneurysm:

36
Heart, T cells, Lymph node, Endothelial, Prostate

Publications for Coronary Artery Aneurysm

About this section

Articles related to Coronary Artery Aneurysm:

(show top 50)    (show all 559)
idTitleAuthorsYear
1
Factors associated with development of coronary artery aneurysms after Kawasaki disease are similar for those treated promptly and those with delayed or no treatment. (28089146)
2017
2
Complex coronary artery aneurysm. (27862313)
2017
3
Coronary Artery Aneurysm After Bioresorbable Vascular Scaffold Implantation With Post-Dilation: Is Less More? (28017314)
2017
4
Hybrid Management of a Giant Left Main Coronary Artery Aneurysm. (28007286)
2017
5
Left Main Coronary Artery Aneurysm. (27403190)
2016
6
Generation of a giant coronary artery aneurysm from an intra-plaque cavity with a ruptured fibrous cap: an observation over time through coronary angiography. (28078177)
2016
7
Rapid Growth of Giant Coronary Artery Aneurysm Following Treatment of StentA Edge Dissection. (27318844)
2016
8
Bilateral Giant Coronary Artery Aneurysms Complicated by Acute Coronary Syndrome and Cardiogenic Shock. (27000621)
2016
9
Technical Considerations of Giant Right Coronary Artery Aneurysm Exclusion. (28018699)
2016
10
Angiographic spontaneous pseudo-resolution of a coronary artery aneurysm after implantation of a sirolimus-eluting stent. (26813572)
2016
11
Giant Coronary Artery Aneurysm Causing Acute Anterior Myocardial Infarction. (27891151)
2016
12
Genome-Wide Association Study Identifies Novel Susceptibility Genes Associated with Coronary Artery Aneurysm Formation in Kawasaki Disease. (27171184)
2016
13
Giant Right Coronary Artery Aneurysm Associated with a Fistula Draining into the Superior Vena Cava. (27547153)
2016
14
Multiple Giant Coronary Artery Aneurysms: A Rare Cause of Sudden Cardiac Death. (27859306)
2016
15
Multiple Coronary Artery Aneurysms and Thoracic Aortitis Associated with IgG4-related Disease. (27301513)
2016
16
Left circumflex coronary artery aneurysm withA arteriovenous fistula to theA coronary sinus presenting as acute coronary syndrome. (27890910)
2016
17
Acute coronary syndrome due to a giant right coronary artery aneurysm. (27773494)
2016
18
Kawasaki Disease With Coronary Artery Aneurysms: Psychosocial Impact on Parents and Children. (28027841)
2016
19
Successful management of a giant unruptured mycotic coronary artery aneurysm after coronary angioplasty. (27751325)
2016
20
Coronary Artery Aneurysm After Everolimus-Eluting Bioabsorbable Vascular Scaffold Implantation. (26793967)
2016
21
Coronary Artery Aneurysm and Coronary Artery Ectasia: What Makes the Difference? (27784732)
2016
22
Cardiac Complications in 38 Cases of Kawasaki Disease with Coronary Artery Aneurysm Diagnosed by Echocardiography. (26711003)
2016
23
Giant left anterior descending coronary artery aneurysm in an adult male patient with ST elevation myocardial infarction. (27021297)
2016
24
Multiple Coronary Artery Aneurysms of the Right Coronary Artery in Neonate with Pulmonary Atresia with Intact Ventricular Septum. (26857432)
2016
25
Giant Right Coronary Artery Aneurysm. (27333780)
2016
26
Percutaneous exclusion of a rapidly enlarging left main coronary artery aneurysm using coils and an Amplatzera8c septal occluder. (26945542)
2016
27
Bare Metal Stent for a Coronary Artery Aneurysm. (26831032)
2016
28
Exclusion of a coronary artery aneurysm using the STENTYS Xposition S balloon-delivery system with optical coherence tomography guidance: precise positioning without trouble. (27649559)
2016
29
How should I treat a patient with giant left main coronary artery aneurysm without associated stenosis? (26788711)
2016
30
Acquired coronary artery aneurysm following treatment with bioresorbable vascular scaffolds. (27753602)
2016
31
From Small Coronary Artery Aneurysm to Giant Left Ventricle Aneurysm. (27603926)
2016
32
Role of gender in types and frequency of coronary artery aneurysm and ectasia. (27495054)
2016
33
Coronary artery aneurysm after sequential stenting with bioresorbable vascular scaffolds. (27845999)
2016
34
Coronary Artery Aneurysm Differs From Coronary Artery Ectasia: Angiographic Characteristics and Cardiovascular Risk Factor Analysis in Patients Referred for Coronary Angiography. (27568385)
2016
35
Successful surgical treatment of a giant right coronary artery aneurysm with a patent left internal thoracic artery graft. (26984288)
2016
36
Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population. (27633390)
2016
37
Right Coronary Artery Aneurysm with Fistula to the Coronary Sinus, Persistent Left Superior Vena Cava, Ruptured Anterior Leaflet Chordae Tendineae with Severe Mitral Regurgitation. (26593222)
2016
38
Giant Right Coronary Artery Aneurysm Mimicking a Mediastinal Cyst With Compression Effects: A Case Report. (27800453)
2016
39
When Is a Coronary Artery Aneurysm Not an Aneurysm? (27106468)
2016
40
Redo Operation of Recurrent Giant Coronary Artery Aneurysm: Optimizing Surgical Strategy. (28018827)
2016
41
Embolic myocardial infarction due to coronary artery aneurysm in a patient with Loeys-Dietz syndrome. (27173863)
2016
42
Galectin-3 and Kawasaki disease patients with special reference to coronary artery aneurysm. (26595790)
2016
43
Development and receding of a coronary artery aneurysm after implantation of a fully bioresorbable scaffold. (25712060)
2015
44
Giant Right Coronary Artery Aneurysm Masquerading as a Pulmonary Embolus. (26432082)
2015
45
Measurements of Coronary Artery Aneurysms Due to Kawasaki Disease by Dual-Source Computed Tomography (DSCT). (26515298)
2015
46
Giant right coronary artery aneurysm. (25648259)
2015
47
Facial nerve palsy, Kawasaki disease, and coronary artery aneurysm. (26101056)
2015
48
Genetic variants in PLCB4/PLCB1 as susceptibility loci for coronary artery aneurysm formation in Kawasaki disease in Han Chinese in Taiwan. (26434682)
2015
49
Case Report: A Rare Case of a Giant Right Coronary Artery Aneurysm. (26306132)
2015
50
Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm. (25573948)
2015

Variations for Coronary Artery Aneurysm

About this section

Expression for genes affiliated with Coronary Artery Aneurysm

About this section
Search GEO for disease gene expression data for Coronary Artery Aneurysm.

Pathways for genes affiliated with Coronary Artery Aneurysm

About this section

Pathways related to Coronary Artery Aneurysm according to GeneCards Suite gene sharing:

(show all 27)
idSuper pathwaysScoreTop Affiliating Genes
110.0MMP1, MMP7
29.8CCL2, VCAM1
39.8KLK3, MMP3, VCAM1
49.8CCL2, MMP1
5
Show member pathways
9.8MMP1, MMP3, VCAM1
69.8PLCB1, PLCB4, VCAM1
79.7MMP13, PLCB1, PLCB4
89.6ITPR3, PLCB1, PLCB4
99.6ITPR3, PLCB1, PLCB4
109.6ITPR3, PLCB1, PLCB4
119.6ITPR3, PLCB1, PLCB4
129.6ITPR3, PLCB1, PLCB4
139.6ITPR3, PLCB1, PLCB4
149.6ITPR3, PLCB1, PLCB4
159.6ITPR3, PLCB1, PLCB4
169.6CCL2, MMP3, VCAM1
179.6ADIPOQ, LEP, VCAM1
189.5CCL2, MMP1, MMP3
19
Show member pathways
9.5CCL2, MMP3, MMP7
209.3CCL2, MMP1, MMP3, VCAM1
219.3CCL2, PLCB1, PLCB4, VCAM1
22
Show member pathways
9.3CCL2, MMP1, MMP13, MMP3
23
Show member pathways
9.2MMP1, MMP12, MMP13, MMP3, MMP7
24
Show member pathways
9.0MMP1, MMP12, MMP13, MMP3, MMP7, VCAM1
259.0KLK3, MMP1, MMP12, MMP13, MMP3, MMP7
26
Show member pathways
8.9CCL17, CCL2, MMP1, MMP13, MMP3
27
Show member pathways
7.2CCL17, CCL2, ITPR3, MMP1, MMP12, MMP13

GO Terms for genes affiliated with Coronary Artery Aneurysm

About this section

Cellular components related to Coronary Artery Aneurysm according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular matrixGO:003101210.0MMP1, MMP12, MMP13, MMP3, MMP7
2proteinaceous extracellular matrixGO:00055789.2MMP1, MMP12, MMP13, MMP3, MMP7
3extracellular regionGO:00055767.8ADIPOQ, CCL17, CCL2, KLK3, LEP, MMP1
4extracellular spaceGO:00056157.7ADIPOQ, CCL17, CCL2, KLK3, LEP, MMP12

Biological processes related to Coronary Artery Aneurysm according to GeneCards Suite gene sharing:

(show all 15)
idNameGO IDScoreTop Affiliating Genes
1leukocyte tethering or rollingGO:005090110.8LEP, VCAM1
2positive regulation of developmental growthGO:004863910.7LEP, PLCB1
3positive regulation of protein oligomerizationGO:003246110.7MMP1, MMP3
4chronic inflammatory responseGO:000254410.5CCL2, VCAM1
5positive regulation of synaptic transmissionGO:005080610.4CCL2, RETN
6cellular response to tumor necrosis factorGO:007135610.1CCL17, CCL2, VCAM1
7response to nutrientGO:000758410.0ADIPOQ, LEP, VCAM1
8response to activityGO:00148239.9ADIPOQ, CCL2, LEP
9collagen catabolic processGO:00305749.9MMP1, MMP12, MMP13, MMP3, MMP7
10extracellular matrix disassemblyGO:00226179.9MMP1, MMP12, MMP13, MMP3, MMP7
11agingGO:00075689.9CCL2, MMP7, RETN, VCAM1
12response to ethanolGO:00454719.7ADIPOQ, CCL2, LEP, VCAM1
13proteolysisGO:00065089.7KLK3, MMP1, MMP12, MMP13, MMP3, MMP7
14response to hypoxiaGO:00016669.6ADIPOQ, CCL2, LEP, VCAM1
15response to nutrient levelsGO:00316679.5ADIPOQ, LEP, MMP7

Molecular functions related to Coronary Artery Aneurysm according to GeneCards Suite gene sharing:

(show all 9)
idNameGO IDScoreTop Affiliating Genes
1endopeptidase activityGO:000417510.3KLK3, MMP1, MMP12, MMP3
2hormone activityGO:000517910.2ADIPOQ, LEP, RETN
3metalloendopeptidase activityGO:00042229.9MMP1, MMP12, MMP13, MMP3, MMP7
4metallopeptidase activityGO:00082379.9MMP1, MMP12, MMP13, MMP3, MMP7
5peptidase activityGO:00082339.7KLK3, MMP1, MMP12, MMP13, MMP3, MMP7
6calcium ion bindingGO:00055099.4ITPR3, MMP1, MMP12, MMP13, MMP3, PLCB1
7serine-type endopeptidase activityGO:00042529.0KLK3, MMP1, MMP12, MMP13, MMP3, MMP7
8receptor bindingGO:00051028.9ADIPOQ, BAG6, CCL17, CCL2, LEP
9hydrolase activityGO:00167878.7ABHD16A, KLK3, MMP1, MMP12, MMP13, MMP3

Sources for Coronary Artery Aneurysm

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet